Header Logo
Newsletter Podcast
Log In
← Back to all posts

Better Outcomes, Better Marketing, Bigger Impact

Jul 15, 2025
Connect

Highlights

  • Today’s Research Article: PRP Outperforms Steroids in Knee OA Relief and the Results Last.
  • Questions from the Field: It’s Not the Centrifuge, It’s What You Do With It.
  • Let’s Get Down to Business: Stop blending in. Learn how patient stories and consistency can turn followers into patients.
  • Come Join Us: Join us in Vegas this July and August for two powerful regenerative medicine experiences you won’t want to miss.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Clinical and Biochemical Correlation of Intraarticular Platelet-Rich Plasma and Corticosteroid Using Serum Matrix Metalloproteinase 3 (MMP-3) Levels in Osteoarthritis of Knee

Vaneet Arora, Manmohan Sharma, Sandeep Bishnoi, Vakul Mahipal, Angad S. Sandhu, Rajat Khanna, Tarun Aggarwal, Krishnadev S. Yadav, Gautam Jain, Shubham M. Sharma

Read the full article here.

Summary:

This study compared the clinical and biochemical outcomes of intra-articular Platelet-Rich Plasma (PRP) versus corticosteroid (CS) injections in patients with knee osteoarthritis (OA). A total of 87 patients with Kellgren-Lawrence grade II and III knee OA were randomly assigned to receive a single injection of either PRP or methylprednisolone. Outcomes were assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Visual Analogue Scale (VAS), and serum levels of Matrix Metalloproteinase-3 (MMP-3). Patients were followed up over nine months.

The findings revealed that PRP provided significantly greater and longer-lasting improvements in pain, stiffness, and joint function compared to CS, as evidenced by lower WOMAC and VAS scores at the 6- and 9-month marks. However, neither treatment led to a significant change in serum MMP-3 levels, suggesting that while both offer symptomatic relief, neither appears to alter cartilage degeneration biochemically. PRP was also found to be safe and minimally invasive, reinforcing its clinical utility in OA knee management.

Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
Evidence, Earnings, Elevation: PRP Outcomes, Pricing & Events
Highlights Today’s Research Article: Early OA? One injection of PRP or HA helps—PRP moves the needle faster.   Questions from the Field: If you measure it, you can price it—structure PRP fees around proven value.   Let’s Get Down to Business: Reclaim your practice—innovate clinically, communicate publicly, mentor boldly.   Come Join Us - Your October sprint: TrueMD Live → ICRS → Apex L...
PRP Research. Real-World Tips. All Roads Lead to TrueMD Live
Highlights Today’s Research Article: PRP beats steroids & PT in SAIS: more pain relief, better function, better QoL at 8 weeks. Questions from the Field: Short-axis halo first, then long-axis—radial or ulnar entry both safe in the median-ulnar “safe zone.” Let’s Get Down to Business: Pick one vivid patient avatar to attract the right clients—and stop saying yes to the wrong ones. Come ...
PRP Evidence, Branding for Doctors & Join Us Live Sept 18
Highlights Today’s Research Article: PRP halved knee-OA pain and boosted function at 6 months—double-blind, same-patient control. Questions from the Field: Yes—drain the effusion, then PRP same day to avoid dilution and clear catabolic enzymes. Let’s Get Down to Business: Patients choose connection over credentials—your personal brand is the clinical edge. Come Join Us: Live PRP demo +...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.